HeartBeam, Inc (BEAT) Reports FY21 Loss of $1.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
HeartBeam Reports Fourth Quarter and Full Year 2021 Financial Results
March 24, 2022 4:01 PM EDTInitiates Strategic Partnerships to Advance Emergency Department (ED) Myocardial Infarction (MI) Software Product & Telehealth Solution Toward FDA Submission
Recent IPO Proceeds Provide Ample Cash Runway to Commercialization in FY 2022 and FY 2023
Management to Host Webcast and Conference Call Today At 4:30 p.m. ET
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary Electrocardiogram (ECG) telemedicine technology for heart attack detection, has reported its financial and operational results for the fourth quarter and full year... More
